20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity
1. DexCom's Q3 2025 revenue reached $1.209 billion, surpassing estimates. 2. U.S. revenue grew 21%, while international revenue increased by 22%. 3. Adjusted earnings of 61 cents beat the consensus forecast of 57 cents. 4. Fiscal 2025 sales guidance raised to $4.63-$4.65 billion, above consensus. 5. Analysts expect significant margin expansion despite current stock price decline.